Cargando…
COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509175/ https://www.ncbi.nlm.nih.gov/pubmed/36168519 http://dx.doi.org/10.1097/HS9.0000000000000780 |
| _version_ | 1784797177793478656 |
|---|---|
| author | Niemann, Carsten U. Awan, Farrukh T. Fogliatto, Laura Nikitin, Eugene Samoilova, Olga Habib, Adel Foroutanpour, Kayhan Kuptsova-Clarkson, Nataliya Opat, Stephen |
| author_facet | Niemann, Carsten U. Awan, Farrukh T. Fogliatto, Laura Nikitin, Eugene Samoilova, Olga Habib, Adel Foroutanpour, Kayhan Kuptsova-Clarkson, Nataliya Opat, Stephen |
| author_sort | Niemann, Carsten U. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9509175 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95091752022-09-26 COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study Niemann, Carsten U. Awan, Farrukh T. Fogliatto, Laura Nikitin, Eugene Samoilova, Olga Habib, Adel Foroutanpour, Kayhan Kuptsova-Clarkson, Nataliya Opat, Stephen Hemasphere Letter Lippincott Williams & Wilkins 2022-09-22 /pmc/articles/PMC9509175/ /pubmed/36168519 http://dx.doi.org/10.1097/HS9.0000000000000780 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letter Niemann, Carsten U. Awan, Farrukh T. Fogliatto, Laura Nikitin, Eugene Samoilova, Olga Habib, Adel Foroutanpour, Kayhan Kuptsova-Clarkson, Nataliya Opat, Stephen COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study |
| title | COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study |
| title_full | COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study |
| title_fullStr | COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study |
| title_full_unstemmed | COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study |
| title_short | COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study |
| title_sort | covid-19 infection in patients with chronic lymphocytic leukemia receiving acalabrutinib in the phase 3b assure study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509175/ https://www.ncbi.nlm.nih.gov/pubmed/36168519 http://dx.doi.org/10.1097/HS9.0000000000000780 |
| work_keys_str_mv | AT niemanncarstenu covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy AT awanfarrukht covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy AT fogliattolaura covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy AT nikitineugene covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy AT samoilovaolga covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy AT habibadel covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy AT foroutanpourkayhan covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy AT kuptsovaclarksonnataliya covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy AT opatstephen covid19infectioninpatientswithchroniclymphocyticleukemiareceivingacalabrutinibinthephase3bassurestudy |